Viking Therapeutics (VKTX) Interest & Investment Income: 2014-2025
Historic Interest & Investment Income for Viking Therapeutics (VKTX) over the last 12 years, with Sep 2025 value amounting to $7.8 million.
- Viking Therapeutics' Interest & Investment Income fell 32.60% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year increase of 7.79%. This contributed to the annual value of $40.9 million for FY2024, which is 172.57% up from last year.
- According to the latest figures from Q3 2025, Viking Therapeutics' Interest & Investment Income is $7.8 million, which was down 13.96% from $9.0 million recorded in Q2 2025.
- Viking Therapeutics' 5-year Interest & Investment Income high stood at $11.8 million for Q2 2024, and its period low was $125,000 during Q3 2021.
- Over the past 3 years, Viking Therapeutics' median Interest & Investment Income value was $7.8 million (recorded in 2025), while the average stood at $7.5 million.
- In the last 5 years, Viking Therapeutics' Interest & Investment Income plummeted by 82.60% in 2021 and then spiked by 1,697.23% in 2023.
- Viking Therapeutics' Interest & Investment Income (Quarterly) stood at $159,000 in 2021, then spiked by 360.38% to $732,000 in 2022, then soared by 542.90% to $4.7 million in 2023, then spiked by 130.43% to $10.8 million in 2024, then slumped by 32.60% to $7.8 million in 2025.
- Its Interest & Investment Income was $7.8 million in Q3 2025, compared to $9.0 million in Q2 2025 and $9.9 million in Q1 2025.